Last updated on April 2018

Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma

Brief description of study

This study looks at the efficacy of Doxycycline for the treatment of Cutaneous T-cell Lymphomas.

Detailed Study Description

The aim of this study is to evaluate the efficacy of doxycycline in relapsed Cutaneous T-cell Lymphomas (CTCL). The primary objective is to determine the overall response rate of doxycycline monotherapy in patients with relapsed CTCL.

Clinical Study Identifier: NCT02341209

Find a site near you

Start Over

Rochester General Hospital

Rochester, NY United States
  Connect »